GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.610
-0.300 (-10.31%)
At close: Nov 20, 2024, 4:00 PM
2.590
-0.020 (-0.77%)
Pre-market: Nov 21, 2024, 5:07 AM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $24.63 million as of November 21, 2024. Its market cap has increased by 75.92% in one year.
Market Cap
24.63M
Enterprise Value
16.04M
1-Year Change
75.92%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $24.63M, an increase of 2,259.06%. That is a compound annual growth rate of 77.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 24.63M | 155.56% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | 176.04K | -83.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 25.51M |
| Equillium | 25.44M |
| Lipocine | 25.19M |
| NEXGEL | 24.81M |
| Athira Pharma | 24.69M |
| DarioHealth | 24.43M |
| Inspira Technologies Oxy B.H.N. | 24.42M |
| Lisata Therapeutics | 24.38M |